Deer Timothy R, Pope Jason E
a 1 CEO Center for pain relief, Charleston, WV, USA.
Expert Rev Clin Pharmacol. 2015;8(5):507-10. doi: 10.1586/17512433.2015.1060577.
Medication selection for neuropathic pain follows a path of evidence, with respect to appreciating the patient's entry into the pain care algorithm. As we decide how to approach neuropathic pain, the considerations for intrathecal therapy medication selection are bound by catheter location, region of pain, and patient selection, to name a few. Future research and the 2016 polyanalgesic consensus conference may further provide patient care through a mindful eye on the improvement of patient safety and a reduction of the societal needs of opioids.
对于神经性疼痛的药物选择遵循循证路径,这涉及到了解患者进入疼痛治疗流程的情况。当我们决定如何处理神经性疼痛时,鞘内治疗药物选择的考量因素包括导管位置、疼痛部位和患者选择等。未来的研究以及2016年多模式镇痛共识会议可能会通过密切关注提高患者安全性和减少社会对阿片类药物的需求,进一步为患者护理提供帮助。